Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01791803 · ClinicalTrials.gov registry record · NA
Smoking Cessation After Hospitalization for a Cardiopulmonary Illness
A NA study of Smoking Cessation, sponsored by North Shore Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 164
- Enrollment target
- 1
- Study location
NCT01791803: Completed NA study of Smoking Cessation, sponsored by North Shore Medical Center.
NCT01791803 is a NA study of Smoking Cessation that has completed, run by North Shore Medical Center. The registered enrollment target is 164 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01791803, a NA study of Smoking Cessation, has completed, sponsored by North Shore Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 164 participants
- Enrollment target
- 1
- Study location
Study Summary
Smoking-related cardiopulmonary diseases account for a large number of hospital admissions. We investigated the efficacy of hypnotherapy as an aid to a counseling-based smoking cessation program in improving quit rates of hospitalized smoking patients at 12 and 26 weeks after hospital discharge. We compared outcomes with hospitalized patients who received more conventional therapy, namely nicotine replacement therapy, or patients who decided to quit on their own. We also compared smoking cessation rates at 12 and 26 weeks after hospitalization among patients admitted with a cardiac or a pulmonary diagnosis.
Primary Outcome
Assessed by 7-day prevalence of verified tobacco abstinence at 26 weeks after hospitalization for a cardiopulmoanry illness. Verification was confirmed biochemically by urine Cotinine testing or by telephone and discussion with a household proxy. Patients lost to follow up were considered to be persistent smokers.
Conditions Studied
Interventions
- DRUG Nicotine
- BEHAVIORAL hypnotherapy
Study Locations (1)
Massachusetts
- North Shore Medical Center - Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2006-01 |
| Est. Completion | 2009-05 |
| Phase | NA |
What the finished NCT01791803 record still lists
NCT01791803 is an interventional study that assigns participants to a tested intervention. The registered 164 participants enrollment target is mid-sized for trials with a published cap, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (65% lower).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Nicotine is the first listed.
NCT01791803 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01791803 about?
NCT01791803 is a clinical study titled "Smoking Cessation After Hospitalization for a Cardiopulmonary Illness". Smoking-related cardiopulmonary diseases account for a large number of hospital admissions. We investigated the efficacy of hypnotherapy as an aid to a counseling-based smoking cessation program in improving quit rates of hospitalized smoking patients at 12 and 26 weeks after hospital discharge. We ...
What is the current status of trial NCT01791803?
This trial is currently completed. It is a NA study. The enrollment target is 164 participants. The study started on 2006-01. Estimated completion is 2009-05.
What conditions does trial NCT01791803 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT01791803?
The interventions under investigation include: Nicotine (DRUG), hypnotherapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01791803?
This trial is sponsored by North Shore Medical Center, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01791803 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01791803's enrollment target sits among peer trials
164 97th of 188 higher than 91 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04891289 · 164 participants · Phase 2
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
- NCT04893226 · 164 participants · NA
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
- NCT05270213 · 164 participants · Phase 1
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
- NCT05543681 · 164 participants · Phase 2
Clinical Trial on Agitation in Alzheimer's Dementia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia